EarningsQ3 2022 Earnings Report

Vir Biotechnology (VIR) Q3 2022 Earnings Report

4 Followers

MX:VIR Q3 2022 EPS Results

Actual EPS$23.35

Consensus EPS-$9.12

Beat/MissBeat by +$32.48

One Year Ago EPS$14.73

Actual Revenue$6.73B

Expected Revenue$2.05B

Beat/MissBeat by +$4.68B

YoY Revenue Growth+261.49%

QuarterQ3 2022

Date11/03/2022

TimeAfter Close

Conference CallThursday, November 3, 2022

MX:VIR Upcoming Earnings

Vir Biotechnology's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-13.27 / -	-21.016	―
Aug 05, 2026	2026 (Q2)	5.98 / 8.44	-14.37	158.75% (+22.81)
May 06, 2026	2026 (Q1)	-1.72 / -15.27	-15.807	3.41% (+0.54)
Feb 23, 2026	2025 (Q4)	-8.82 / -5.57	-13.651	59.21% (+8.08)
Nov 05, 2025	2025 (Q3)	-15.16 / -21.02	-28.021	25.00% (+7.01)
Aug 06, 2025	2025 (Q2)	-12.99 / -14.37	-18.322	21.57% (+3.95)
May 07, 2025	2025 (Q1)	-15.02 / -15.81	-8.622	-83.33% (-7.18)
Feb 26, 2025	2024 (Q4)	-15.66 / -13.65	-15.448	11.63% (+1.80)
Oct 31, 2024	2024 (Q3)	-18.90 / -28.02	-21.914	-27.87% (-6.11)
Aug 01, 2024	2024 (Q2)	-16.08 / -18.32	-26.045	29.66% (+7.72)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed